- Home
- FIVN vs RXRX Comparison
FIVN vs RXRX Comparison
Compare FIVN & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FIVN | RXRX |
|---|---|---|
| Founded | 2001 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.9B |
| IPO Year | 2014 | 2021 |
Fundamental Metrics
Financial Performance| Metric | FIVN | RXRX |
|---|---|---|
| Price | $19.48 | $3.24 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 18 | 4 |
| Target Price | ★ $26.06 | $7.50 |
| AVG Volume (30 Days) | 2.9M | ★ 20.5M |
| Earning Date | 04-30-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 364.71 | 14.79 |
| EPS | ★ 0.21 | N/A |
| Revenue | ★ $1,149,088,000.00 | $74,681,000.00 |
| Revenue This Year | $11.39 | $12.11 |
| Revenue Next Year | $10.00 | $82.52 |
| P/E Ratio | $90.76 | ★ N/A |
| Revenue Growth | 10.28 | ★ 26.92 |
| 52 Week Low | $13.29 | $2.77 |
| 52 Week High | $29.71 | $7.18 |
Technical Indicators
Market Signals| Indicator | FIVN | RXRX |
|---|---|---|
| Relative Strength Index (RSI) | 40.78 | 48.79 |
| Support Level | $17.25 | $2.88 |
| Resistance Level | $19.63 | $4.01 |
| Average True Range (ATR) | 1.40 | 0.26 |
| MACD | -0.52 | -0.01 |
| Stochastic Oscillator | 16.56 | 24.31 |
Price Performance
Historical ComparisonAbout FIVN Five9 Inc.
Five9 offers cloud-native contact center software enabling digital customer service, sales, and marketing engagement. The company's Intelligent CX platform combines core telephony functionality, omnichannel engagement, and modules into a cloud contact-center-as-a-service, or CCaaS, platform. Five9's modules include digital self-service, agent assist technology, workflow automation, and optimization solutions, as well as artificial intelligence-driven automation solutions that optimize customer service efficiency and manage interaction quality and agent performance.
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Geographically, the company operates in United States, United Kingdom, and Others. It derives maximum revenue from United States.